ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Ubretid®:Takeda Pharma AG
Complete information for professionalsDDDPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
Registration ownerLast update of information 
N07AA03 - DistigmineATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N07 - Other Nervous System Drugs

This group comprises other nervous system drugs, which cannot be classified in the preceding 2nd levels in ATC group N.

N07A - Parasympathomimetics

See also cholinergics used in glaucoma therapy, S01EB.

This group includes various drugs used for different indications. The DDDs are therefore established individually for each ATC 5th level.

N07AA - Anticholinesterases
 
N07AA03 - Distigmine
DoseRoute of administrationNote
 P 
 O 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home